Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $2.55 Million - $3.02 Million
-37,300 Reduced 89.88%
4,200 $302,000
Q3 2022

Oct 25, 2022

BUY
$0.13 - $76.84 $1,599 - $945,132
12,300 Added 42.12%
41,500 $2.95 Million
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $3.49 Million - $3.85 Million
-48,100 Reduced 62.23%
29,200 $2.25 Million
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $4.75 Million - $5.7 Million
77,300 New
77,300 $5.65 Million
Q4 2021

Jan 31, 2022

SELL
$53.63 - $62.52 $1.38 Million - $1.61 Million
-25,700 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $384,605 - $450,515
6,500 Added 33.85%
25,700 $1.52 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $1.02 Million - $1.11 Million
16,400 Added 585.71%
19,200 $1.28 Million
Q1 2021

May 03, 2021

BUY
$59.34 - $66.74 $41,538 - $46,718
700 Added 33.33%
2,800 $177,000
Q4 2020

Jan 29, 2021

BUY
$57.74 - $65.43 $121,254 - $137,403
2,100 New
2,100 $129,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Qvr LLC Portfolio

Follow Qvr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvr LLC with notifications on news.